Over the past two months, at least four Xarelto lawsuits have been filed in Connecticut on behalf of patients who allegedly experienced uncontrollable internal bleeding following use of the new-generation anticoagulant. According to court documents, all of the complaints have since been transferred to the U.S. District Court, Eastern District of Louisiana, where hundreds of similar Xarelto bleeding claims have been consolidated for coordinated pretrial proceedings.
All of the Connecticut lawsuits name Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer HealthCare Pharmaceutical as defendants, and allege that Xarelto can cause “bleeding that cannot be stopped because there’s no antidote.” The companies are accused of misleading patients and doctors by marketing the blood thinner as a superior alternative to warfarin, and promising that the new medication would not require monitoring of blood plasma levels. However, plaintiffs assert that Xarelto users might actually benefit from regular monitoring, and point out that warfarin bleeding can be stopped via the administration of vitamin K.
Xarelto was first approved by the U.S. Food & Drug Administration (FDA) in 2011. According to the lawsuits filed in Connecticut and elsewhere, by the end of 2012, the FDA had received reports of some 2,080 Xarelto-related injuries, including 151 deaths.
Just over 300 Xarelto lawsuits are now pending in the multidistrict litigation underway in Louisiana. The proceeding was only created in December 2014, and is still in its early stages. However, Xarelto lawyers around the country are reportedly hearing from numerous people who were allegedly harmed by the drug, and some have speculated that many more such claims will be filed. The multidistrict litigation was created in anticipation of a large number of filings, and will allow federal Xarelto lawsuits to proceed more efficiently through the court system.
In addition to the federal multidistrict litigation, a mass tort proceeding has been established in the Philadelphia Court of Common Pleas for all Xarelto bleeding cases filed in Pennsylvania’s state courts. So far, just over 150 cases are pending in the proceeding.
Bernstein Liebhard LLP is representing a number of clients in Xarelto lawsuits, and our legal staff continues to offer free, no-obligation consultations to individuals who may have been harmed by this medication. To learn more, please contact one of our Xarelto lawyers by calling .